(NewsDirect)
Eden Research PLC (AIM:EDEN, OTCQB:EDNSF)CEO Sean Smith speaks to Thomas Warner from Proactive following a busyperiod for the sustainable biopesticide company that has included thepublication of interim results, the first commercial order for itsseed treatment Ecovelex and a £9.9mln fundraise.
Smith addresses the interims first,highlighting the company's steady progress despite challengingmarket conditions particularly in southern Europe. He goes on todiscuss the company's new bird-repelling seed treatment, Ecovelex,developed in partnership with Corteva Agriscience, the world'slargest agriscience pure play company. Ecovelex is awaiting regulatoryclearance, with farmers in the UK and Italy petitioning for emergencyapproval due to the removal of a current product from themarket.
He finishes by revealingmore details about what Eden Research investors can expect the companyto do with the proceeds of a £9.9mln fundraise, noting that Eden willbe working to support the commercialisation of Ecovelex as movestoward regulatory clearance.
He also mentions a potential newinsecticide product "which is currently undergoing trials in morethan 140 different locations around the world."
ContactDetails
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.